Johnson & Johnson diskutieren
Johnson & Johnson
WKN: 853260 / Symbol: JNJ / Name: Johnson & Johnson / Aktie / Pharmazeutika / Large Cap /
177,66 €
-0,59 %
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Raymond James from $170.00 to $165.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Leerink Partners from $182.00 to $169.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $172.00 price target on the stock, up previously from $157.00.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Raymond James from $165.00 to $162.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "underperform" rating re-affirmed by analysts at Morgan Stanley.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at UBS Group AG from $180.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Royal Bank Of Canada from $181.00 to $185.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Piper Sandler.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Citigroup Inc. from $185.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $185.00 to $186.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE:JNJ) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $206.00 price target on the stock, up previously from $167.00.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE:JNJ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $212.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE:JNJ) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for JNJ provided by MarketBeat
Neueste Beiträge
The_Goldman_Sachs_Gr in Accenture plc A diskutieren